Glycaemic Variability – Assessment with CGM / AGP Read more about Glycaemic Variability – Assessment with CGM / AGP
Diabetes distress: practical considerations Read more about Diabetes distress: practical considerations
Inpatient Diabetes in the 21st Century: CSI or CSII Read more about Inpatient Diabetes in the 21st Century: CSI or CSII
A deep dive into the semaglutide (Ozempic ) SUSTAIN programme Read more about A deep dive into the semaglutide (Ozempic ) SUSTAIN programme
Proinsulin peptide C19-A3 immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced total daily insulin usage Read more about Proinsulin peptide C19-A3 immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced total daily insulin usage
